Ashok Sharma
Cardiovascular Disease · Mahwah, NJNPI 1497804405
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 95 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 18.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $559 and has fallen 83.3% since, to $93 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in NJ, where the typical reported total is $2,633.
Across 95 payments — averaging $19.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$333
- Johnson & Johnson$258
- Amgen$183
- E.r. Squibb & Sons, L.L.C.$168
- Pharmacyclics LLC, An Abbvie Company$101
- AbbVie$93
- plus $674 from 23 others
What the payments were for
- Food & beverage$1,810100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 2 | $333 |
| Johnson & Johnson(2 entities) | 14 | $258 |
| Amgen | 12 | $183 |
| E.r. Squibb & Sons, L.L.C. | 12 | $168 |
| Pharmacyclics LLC, An Abbvie Company | 7 | $101 |
| AbbVie | 4 | $93 |
| Eisai Inc. | 5 | $88 |
| AstraZeneca(2 entities) | 5 | $74 |
| Bristol Myers Squibb | 5 | $66 |
| Kowa Pharmaceuticals America, Inc. | 4 | $55 |
| Incyte Corporation | 3 | $45 |
| Boehringer Ingelheim | 3 | $42 |
| Bayer | 2 | $33 |
| Pfizer | 2 | $27 |
| AVEO Pharmaceuticals, Inc. | 1 | $21 |
| Coherus Oncology, Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Spectrum Pharmaceuticals Inc. | 1 | $17 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| Seagen Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Octapharma USA, Inc. | 1 | $15 |
| EUSA Pharma (US) LLC | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Reveal LINQ$333
How this compares
$1,810 in reported general payments places this provider in the 40th percentile of 1,006 cardiovascular disease providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 11 | $129 |
| Amlodipine Besylate | 19 | $102 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Mahwah
- Marc CohenNewark$762K
- Peter FarrugiaColts Neck$600K
- Felix Dailey-SterlingGuttenberg$568K
- Ramzan ZakirNew Brunswick$342K
- Richard KovachBrowns Mills$300K
- Andrea RussoCamden$293K
- John KostisNew Brunswick$225K
- Dilip ViswanathHaddon Heights$167K
- David PowellSpringfield$162K
- Fadi ChaabanWest Orange$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.